バスキュラーアクセス手技市場- 世界の産業規模、シェア、動向、機会、予測、手技別、用途別、地域別、競合別、2020-2030年

バスキュラーアクセス手技の世界市場規模は2024年に913億5,000万米ドルで、2030年にはCAGR 5.38%で1,252億8,000万米ドルに達すると予測されています。

バスキュラーアクセス手技の世界市場は、ヘルスケア需要の増加と慢性疾患の負担増により、大幅な拡大が見られます。中心静脈カテーテル、末梢挿入型中心静脈カテーテル（PICC）、動静脈瘻などの挿入を含むバスキュラーアクセス手技は、投薬、栄養管理、透析、採血に不可欠です。がん、腎臓病、心血管疾患などの慢性疾患による入院の増加により、効率的で長期的なバスキュラーアクセスソリューションの必要性が急増しています。定期的な医療介入を必要とする併存疾患を抱えやすい世界人口の高齢化も、手術件数の増加に寄与しています。手術件数の増加、入院期間の長期化、ポータブル輸液装置による在宅医療への嗜好の高まりは、安全で信頼性が高く挿入が容易なバスキュラーアクセス装置に対する市場の需要を加速させています。

市場は、注目すべき技術革新や動向によっても形成されています。抗菌コーティングや超音波ガイド下挿入技術など、カテーテルの素材や設計の進歩により、感染症や血栓症などの合併症が減少しています。画像技術やナビゲーション技術がバスキュラーアクセス手技に統合されたことで、器具の挿入がより正確になり、挿入失敗率が低下しています。低侵襲アクセス技術へのシフトは、特に外来患者や外来環境において支持を集めており、患者の快適性の向上とヘルスケアコストの削減につながっています。市場参入企業は、大規模病院と低リソース環境の両方に対応する、使いやすく費用対効果の高い機器の発売に注力しています。医療従事者の間では、機器の選択と挿入プロトコルに関するトレーニングと意識が高まっており、手技の成功率と患者の安全性がさらに向上しています。

このような好況にもかかわらず、世界バスキュラーアクセス手技市場にはいくつかの課題が残っています。高度なバスキュラーアクセス機器や手技に関連する高額なコストは、低所得層や資源に乏しい環境での採用を制限する可能性があります。カテーテル関連血流感染（CRBSI）、閉塞、機械的故障などのデバイス関連合併症は、依然として重大な臨床リスクをもたらしています。臨床医の技術レベルにばらつきがあり、挿入手技が施設間で標準化されていないため、患者の転帰に一貫性がないことが多いです。新しいバスキュラーアクセスデバイスの承認に対する厳しい規制要件は、製品の発売を遅らせ、技術革新を妨げる可能性があります。さらに、器具の耐久性、頻繁な交換、および患者の不快感に対する懸念は、一部の患者集団における採用を妨げる可能性があります。トレーニングの改善、患者に特化した機器設計、継続的な臨床研究を通じてこれらの課題に対処することは、市場の持続的成長を確保する上で極めて重要です。

主な市場促進要因

長期的な血管アクセスを必要とする慢性疾患の有病率の増加

主な市場課題

バスキュラーアクセス機器に伴う合併症の高リスク

主な市場動向

画像誘導型バスキュラーアクセス技術の採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバスキュラーアクセス手技市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 術式別（動静脈瘻、動静脈グラフト、中心静脈カテーテル、その他）
  • 用途別（化学療法、血液透析、輸血、静脈内抗生物質治療、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のバスキュラーアクセス手技市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のバスキュラーアクセス手技市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のバスキュラーアクセス手技市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のバスキュラーアクセス手技市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバスキュラーアクセス手技市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Teleflex Incorporated
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Cook Group Incorporated
• AngioDynamics, Inc.
• Medtronic plc
• Medical Components, Inc.
• Terumo Corporation
• Access Vascular, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Vascular Access Procedures Market was valued at USD 91.35 Billion in 2024 and is expected to reach USD 125.28 Billion by 2030 with a CAGR of 5.38%. The Global Vascular Access Procedures Market is witnessing substantial expansion as a result of increasing healthcare demands and the growing burden of chronic illnesses. Vascular access procedures, which include the insertion of devices such as central venous catheters, peripherally inserted central catheters (PICCs), and arteriovenous fistulas, are critical for administering medications, nutrition, dialysis, and for blood sampling. A rise in hospital admissions for chronic conditions like cancer, kidney disease, and cardiovascular ailments has led to a corresponding surge in the need for efficient and long-term vascular access solutions. The aging global population, which is more prone to comorbidities requiring regular medical interventions, is also contributing to higher procedure volumes. Rising surgical volumes, longer hospital stays, and increasing preferences for home-based care with portable infusion devices are accelerating the market demand for safe, reliable, and easy-to-insert vascular access devices.

The market is also shaped by notable technological innovations and trends. Advancements in catheter materials and designs, such as antimicrobial coatings and ultrasound-guided insertion techniques, are reducing complications such as infections and thrombosis. The integration of imaging and navigation technologies into vascular access procedures is making device placement more accurate and reducing the rate of failed insertions. A shift toward minimally invasive access techniques is gaining traction, particularly in outpatient and ambulatory settings, leading to improved patient comfort and reduced healthcare costs. Market participants are focusing on launching user-friendly and cost-effective devices that cater to both high-volume hospitals and low-resource settings. Increasing training and awareness among healthcare providers regarding device selection and insertion protocols is further improving procedural success rates and patient safety.

Despite the positive momentum, several challenges persist in the Global Vascular Access Procedures Market. High costs associated with advanced vascular access devices and procedures can limit their adoption in lower-income or resource-constrained settings. Device-related complications such as catheter-related bloodstream infections (CRBSIs), occlusions, and mechanical failures continue to pose significant clinical risks. Variability in clinician skill levels and lack of standardized insertion techniques across facilities often result in inconsistent patient outcomes. Stringent regulatory requirements for the approval of new vascular access devices may delay product launches and hinder innovation. Moreover, concerns over device durability, frequent replacements, and patient discomfort may discourage adoption in some patient populations. Addressing these challenges through improved training, patient-specific device design, and ongoing clinical studies will be crucial in ensuring sustainable market growth.

Key Market Drivers

Growing Prevalence of Chronic Diseases Requiring Long-term Vascular Access

The growing prevalence of chronic diseases that require long-term vascular access is one of the most significant drivers of the Global Vascular Access Procedures Market. Chronic kidney disease (CKD) alone affects more than 800 million people globally, accounting for over 10% of the world's population, and its prevalence continues to increase, especially in low- and middle-income countries due to rising rates of diabetes and hypertension. A large proportion of CKD patients depend on hemodialysis, which demands reliable vascular access methods such as arteriovenous fistulas, grafts, and central venous catheters. These access points are critical for ensuring efficient dialysis sessions and improving patient survival outcomes.

Cancer incidence is another major factor contributing to market growth. In 2022, there were nearly 20 million new cancer cases and about 9.7 million deaths worldwide. Many cancer patients undergo chemotherapy, targeted therapy, and supportive treatments requiring long-term intravenous access through devices like implantable ports or peripherally inserted central catheters (PICCs). In parallel, the burden of severe infections and sepsis remains extremely high, with 48.9 million cases and 11 million related deaths annually, representing one in every five deaths globally. These cases frequently necessitate prolonged antibiotic administration via secure vascular access devices.

Technological advancements have further strengthened the role of vascular access procedures in chronic disease management. The introduction of antimicrobial-coated catheters, ultrasound-guided insertion techniques, and needle-free connectors has improved safety, reduced infection risks, and extended device longevity. Growing awareness among healthcare providers about early vascular access planning, especially for patients with progressive chronic illnesses, is improving treatment efficiency and patient quality of life. With aging populations and rising comorbidity rates, demand for dependable, long-term vascular access solutions is expected to accelerate, driving substantial market expansion in the years ahead.

Key Market Challenges

High Risk of Complications Associated with Vascular Access Devices

The Global Vascular Access Procedures Market faces a significant challenge due to the high risk of complications associated with vascular access devices, which can impact patient outcomes and limit procedural adoption. Complications such as catheter-related bloodstream infections (CRBSIs), thrombosis, stenosis, hematoma formation, and device malfunction are common concerns that can arise during or after the procedure. Infections remain one of the most critical risks, as they not only lead to increased morbidity but also escalate healthcare costs due to prolonged hospital stays, additional treatments, and the need for device replacement. Thrombosis and stenosis can compromise the efficiency of vascular access, requiring repeat interventions that increase the burden on both healthcare systems and patients. In certain cases, repeated procedures can lead to limited viable access sites, especially in patients undergoing long-term treatments like hemodialysis or chemotherapy.

The risk of complications is amplified in patients with multiple comorbidities, weakened immune systems, or poor vascular health, making device placement and maintenance more challenging. A lack of standardized training protocols for device insertion and maintenance in some regions contributes to procedural variability, which can further elevate complication rates. Concerns about these risks often lead to hesitancy among healthcare providers and patients, slowing adoption of advanced vascular access solutions despite their potential benefits. This challenge necessitates continuous innovation in device design, incorporation of antimicrobial coatings, and the implementation of strict infection control protocols. Without addressing these safety concerns effectively, market growth may be hindered due to the potential for adverse events that undermine trust in vascular access procedures.

Key Market Trends

Rising Adoption of Image-Guided Vascular Access Techniques

The Global Vascular Access Procedures Market is witnessing a notable trend with the rising adoption of image-guided vascular access techniques, driven by the growing demand for precision, safety, and efficiency in medical interventions. Image-guided procedures, using ultrasound, fluoroscopy, or other imaging modalities, allow clinicians to visualize the vascular anatomy in real time, significantly reducing the risk of complications such as arterial puncture, hematoma, or catheter misplacement. This approach is particularly valuable in complex patient cases, including those with challenging vascular anatomy, pediatric patients, and individuals requiring repeated access for treatments like dialysis or chemotherapy. The integration of imaging technologies into vascular access workflows is improving first-attempt success rates, minimizing patient discomfort, and reducing procedure time, which enhances both clinical outcomes and operational efficiency in healthcare settings.

Technological advancements in portable and handheld ultrasound devices are expanding the accessibility of image-guided procedures beyond specialized centers to community hospitals and outpatient clinics. This trend is also supported by growing clinical evidence demonstrating superior safety profiles and long-term patency rates when image guidance is employed. Training initiatives and skill development programs by medical societies and device manufacturers are equipping healthcare professionals with the expertise to adopt these techniques more widely. As healthcare systems prioritize patient safety, cost-effectiveness, and adherence to evidence-based practices, the shift toward image-guided vascular access is becoming a standard of care across multiple therapeutic areas, positioning it as a critical driver of procedural evolution in the market.

Key Market Players

• Teleflex Incorporated
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Cook Group Incorporated
• AngioDynamics, Inc.
• Medtronic plc
• Medical Components, Inc.
• Terumo Corporation
• Access Vascular, Inc.

Report Scope:

In this report, the Global Vascular Access Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Access Procedures Market, By Procedure:

• Arteriovenous Fistulas
• Arteriovenous Grafts
• Central Venous Catheters
• Others

Vascular Access Procedures Market, By Application:

• Chemotherapy
• Hemodialysis
• Blood Transfusions
• Intravenous Antibiotics Treatment
• Others

Vascular Access Procedures Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Access Procedures Market.

Available Customizations:

Global Vascular Access Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Vascular Access Procedures Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure (Arteriovenous Fistulas, Arteriovenous Grafts, Central Venous Catheters, Others)
  • 5.2.2. By Application (Chemotherapy, Hemodialysis, Blood Transfusions, Intravenous Antibiotics Treatment, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Vascular Access Procedures Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vascular Access Procedures Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Vascular Access Procedures Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Vascular Access Procedures Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure
      • 6.3.3.2.2. By Application

7. Europe Vascular Access Procedures Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Vascular Access Procedures Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Vascular Access Procedures Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Vascular Access Procedures Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Vascular Access Procedures Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Vascular Access Procedures Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure
      • 7.3.5.2.2. By Application

8. Asia-Pacific Vascular Access Procedures Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vascular Access Procedures Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure
      • 8.3.1.2.2. By Application
  • 8.3.2. India Vascular Access Procedures Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Vascular Access Procedures Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Vascular Access Procedures Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Vascular Access Procedures Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure
      • 8.3.5.2.2. By Application

9. South America Vascular Access Procedures Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vascular Access Procedures Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Vascular Access Procedures Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Vascular Access Procedures Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure
      • 9.3.3.2.2. By Application

10. Middle East and Africa Vascular Access Procedures Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vascular Access Procedures Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Vascular Access Procedures Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Vascular Access Procedures Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Teleflex Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. B. Braun Melsungen AG
• 15.4. ICU Medical, Inc.
• 15.5. Cook Group Incorporated
• 15.6. AngioDynamics, Inc.
• 15.7. Medtronic plc
• 15.8. Medical Components, Inc.
• 15.9. Terumo Corporation
• 15.10. Access Vascular, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer